197 related articles for article (PubMed ID: 37695055)
21. Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.
Cartwright HN; Barbeau DJ; Doyle JD; Klein E; Heise MT; Ferris MT; McElroy AK
PLoS Pathog; 2022 Jul; 18(7):e1010649. PubMed ID: 35834486
[TBL] [Abstract][Full Text] [Related]
22. Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity.
Le Coupanec A; Babin D; Fiette L; Jouvion G; Ave P; Misse D; Bouloy M; Choumet V
PLoS Negl Trop Dis; 2013; 7(6):e2237. PubMed ID: 23785528
[TBL] [Abstract][Full Text] [Related]
23. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.
Wichgers Schreur PJ; Oreshkova N; Moormann RJ; Kortekaas J
J Virol; 2014 Sep; 88(18):10883-93. PubMed ID: 25008937
[TBL] [Abstract][Full Text] [Related]
24. Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice.
Morrill JC; Peters CJ; Bettinger GE; Palermo PM; Smith DR; Watts DM
Vaccine; 2022 Nov; 40(50):7255-7261. PubMed ID: 36333222
[TBL] [Abstract][Full Text] [Related]
25. Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection.
Bermúdez-Méndez E; Angelino P; van Keulen L; van de Water S; Rockx B; Pijlman GP; Ciuffi A; Kortekaas J; Wichgers Schreur PJ
J Virol; 2023 Jun; 97(6):e0041523. PubMed ID: 37306574
[TBL] [Abstract][Full Text] [Related]
26. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
[TBL] [Abstract][Full Text] [Related]
27. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
[TBL] [Abstract][Full Text] [Related]
28. Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Young Lambs.
Odendaal L; Davis AS; Fosgate GT; Clift SJ
Vet Pathol; 2020 Jan; 57(1):66-81. PubMed ID: 31842723
[TBL] [Abstract][Full Text] [Related]
29. Rift Valley Fever Virus Propagates in Human Villous Trophoblast Cell Lines and Induces Cytokine mRNA Responses Known to Provoke Miscarriage.
Gwon YD; Nematollahi Mahani SA; Nagaev I; Mincheva-Nilsson L; Evander M
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835071
[TBL] [Abstract][Full Text] [Related]
30. Mouse model for the Rift Valley fever virus MP12 strain infection.
Lang Y; Henningson J; Jasperson D; Li Y; Lee J; Ma J; Li Y; Cao N; Liu H; Wilson W; Richt J; Ruder M; McVey S; Ma W
Vet Microbiol; 2016 Nov; 195():70-77. PubMed ID: 27771072
[TBL] [Abstract][Full Text] [Related]
31. Molecular aspects of Rift Valley fever virus and the emergence of reassortants.
Gaudreault NN; Indran SV; Balaraman V; Wilson WC; Richt JA
Virus Genes; 2019 Feb; 55(1):1-11. PubMed ID: 30426314
[TBL] [Abstract][Full Text] [Related]
32. Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
Walters AW; Kujawa MR; Albe JR; Reed DS; Klimstra WB; Hartman AL
Virology; 2019 Jan; 526():173-179. PubMed ID: 30396029
[TBL] [Abstract][Full Text] [Related]
33. Culex flavivirus infection in a Culex pipiens mosquito colony and its effects on vector competence for Rift Valley fever phlebovirus.
Talavera S; Birnberg L; Nuñez AI; Muñoz-Muñoz F; Vázquez A; Busquets N
Parasit Vectors; 2018 May; 11(1):310. PubMed ID: 29792223
[TBL] [Abstract][Full Text] [Related]
34. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
35. The pathogenesis of Rift Valley fever virus in the mouse model.
Smith DR; Steele KE; Shamblin J; Honko A; Johnson J; Reed C; Kennedy M; Chapman JL; Hensley LE
Virology; 2010 Nov; 407(2):256-67. PubMed ID: 20850165
[TBL] [Abstract][Full Text] [Related]
36. The pathogenesis of Rift Valley fever.
Ikegami T; Makino S
Viruses; 2011 May; 3(5):493-519. PubMed ID: 21666766
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructural study of Rift Valley fever virus in the mouse model.
Reed C; Steele KE; Honko A; Shamblin J; Hensley LE; Smith DR
Virology; 2012 Sep 15-30; 431(1-2):58-70. PubMed ID: 22687428
[TBL] [Abstract][Full Text] [Related]
38. Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.
Barbeau DJ; Albe JR; Nambulli S; Tilston-Lunel NL; Hartman AL; Lakdawala SS; Klein E; Duprex WP; McElroy AK
mSphere; 2020 Oct; 5(5):. PubMed ID: 33115835
[TBL] [Abstract][Full Text] [Related]
39. Identification of Host Factors for Rift Valley Fever Phlebovirus.
Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928
[TBL] [Abstract][Full Text] [Related]
40. Genetic dissection of Rift Valley fever pathogenesis: Rvfs2 locus on mouse chromosome 11 enables survival to early-onset hepatitis.
Batista L; Jouvion G; Simon-Chazottes D; Houzelstein D; Burlen-Defranoux O; Boissière M; Tokuda S; do Valle TZ; Cumano A; Flamand M; Montagutelli X; Panthier JJ
Sci Rep; 2020 May; 10(1):8734. PubMed ID: 32457349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
